2,5-Disubstituted furan derivatives containing 1,3,4-thiadiazole moiety as potent α-glucosidase and E. coli β-glucuronidase inhibitors.

[1]  Jianwei Chen,et al.  Characterization and hypoglycemic effects of sulfated polysaccharides derived from brown seaweed Undaria pinnatifida. , 2020, Food chemistry.

[2]  Hong Wang,et al.  New cembrane-type diterpenoids from the South China Sea soft coral Sinularia crassa and their α-glucosidase inhibitory activity. , 2020, Bioorganic chemistry.

[3]  Zi-Ning Cui,et al.  Thiazolidin-2-cyanamides derivatives as novel potent Escherichia coli β-glucuronidase inhibitors and their structure–inhibitory activity relationships , 2020, Journal of enzyme inhibition and medicinal chemistry.

[4]  M. Emam,et al.  Cinnamic acid derivatives: inhibitory activity against Escherichia coli β-glucuronidase and structure–activity relationships , 2020, Journal of enzyme inhibition and medicinal chemistry.

[5]  Paul Awolade,et al.  Therapeutic significance of β-glucuronidase activity and its inhibitors: A review , 2019, European Journal of Medicinal Chemistry.

[6]  Zi-Ning Cui,et al.  Synthesis and biological evaluation of 1,3,4-thiadiazole derivatives as type III secretion system inhibitors against Xanthomonas oryzae. , 2019, Pesticide biochemistry and physiology.

[7]  Yasser A. Bamarouf,et al.  Synthesis of oxadiazole-coupled-thiadiazole derivatives as a potent β-glucuronidase inhibitors and their molecular docking study. , 2019, Bioorganic & medicinal chemistry.

[8]  I. Matić,et al.  Novel 1,3,4-thiadiazole-chalcone hybrids containing catechol moiety: synthesis, antioxidant activity, cytotoxicity and DNA interaction studies. , 2018, MedChemComm.

[9]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[10]  Qing-Wen Zhang,et al.  Prenylflavonoids sanggenon C and kuwanon G from mulberry (Morus alba L.) as potent broad-spectrum bacterial β-glucuronidase inhibitors: Biological evaluation and molecular docking studies , 2018, Journal of Functional Foods.

[11]  Ru Yan,et al.  Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing β-glucuronidase from Staphylococcus pasteuri 3I10 , 2018, Applied Microbiology and Biotechnology.

[12]  M. Redinbo,et al.  Gut Microbial beta-Glucuronidase Inhibition via Catalytic Cycle Interception. , 2018 .

[13]  M. Woodward,et al.  Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events , 2018, Diabetologia.

[14]  M. Redinbo,et al.  Gut Microbial β-Glucuronidase Inhibition via Catalytic Cycle Interception , 2018, ACS central science.

[15]  Yixian Liao,et al.  Synthesis and biological evaluation of 2,5-disubstituted furan derivatives as P-glycoprotein inhibitors for Doxorubicin resistance in MCF-7/ADR cell. , 2018, European journal of medicinal chemistry.

[16]  M. Mansourian,et al.  Different effects of metformin and insulin on primary and secondary chemoprevention of colorectal adenoma in diabetes type 2: Traditional and Bayesian meta-analysis , 2018, EXCLI journal.

[17]  C. Tzeng,et al.  Specific Inhibition of Bacterial β-Glucuronidase by Pyrazolo[4,3-c]quinoline Derivatives via a pH-Dependent Manner To Suppress Chemotherapy-Induced Intestinal Toxicity. , 2017, Journal of medicinal chemistry.

[18]  Ghada S. Hassan,et al.  Synthesis, biological evaluation and molecular modeling study of new (1,2,4-triazole or 1,3,4-thiadiazole)-methylthio-derivatives of quinazolin-4(3H)-one as DHFR inhibitors. , 2017, Bioorganic chemistry.

[19]  N. Ismail,et al.  Thiadiazole derivatives as New Class of β-glucuronidase inhibitors. , 2016, Bioorganic & medicinal chemistry.

[20]  Y. Wang,et al.  Synthesis and fungicidal activity of novel 2,5-disubstituted-1,3,4- thiadiazole derivatives containing 5-phenyl-2-furan , 2016, Scientific Reports.

[21]  Yong-Hua Yang,et al.  1,3,4-Thiadiazole: synthesis, reactions, and applications in medicinal, agricultural, and materials chemistry. , 2014, Chemical reviews.

[22]  T. Kelly,et al.  Diabetes Mellitus and Colorectal Cancer Prognosis: A Meta-analysis , 2013, Diseases of the colon and rectum.

[23]  Fuming Xu,et al.  Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth. , 2013, European journal of medicinal chemistry.

[24]  A. Jain,et al.  1,3,4‐Thiadiazole and its Derivatives: A Review on Recent Progress in Biological Activities , 2013, Chemical biology & drug design.

[25]  C. Spencer,et al.  Miglitol , 2000, Drugs.

[26]  A. Shafiee,et al.  Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substituents. , 2011, European journal of medicinal chemistry.

[27]  C. Draghici,et al.  Synthesis and antimicrobial evaluation of some fused heterocyclic [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives. , 2010, European journal of medicinal chemistry.

[28]  Matthew R. Redinbo,et al.  Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme , 2010, Science.

[29]  Keizo Yamamoto,et al.  Crystal structures of isomaltase from Saccharomyces cerevisiae and in complex with its competitive inhibitor maltose , 2010, The FEBS journal.

[30]  Qingquan Yu,et al.  Research Article: Synthesis, Biological Evaluation and Molecular Modeling Studies of N‐aryl‐2‐arylthioacetamides as Non‐nucleoside HIV‐1 Reverse Transcriptase Inhibitors , 2010, Chemical biology & drug design.

[31]  A. Nicolucci.  Epidemiological aspects of neoplasms in diabetes , 2010, Acta Diabetologica.

[32]  Zhang Li-ping.  Retrospective analysis of the relationship between type 2 diabetes mellitus and colorectal cancer , 2009 .

[33]  Y. Pommier.  Topoisomerase I inhibitors: camptothecins and beyond , 2006, Nature Reviews Cancer.

[34]  Igor V. Tetko,et al.  Virtual Computational Chemistry Laboratory – Design and Description , 2005, J. Comput. Aided Mol. Des..

[35]  H. Holzhausen,et al.  Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in rats , 2004, Journal of Cancer Research and Clinical Oncology.

[36]  E. Gulve,et al.  Chemistry and biochemistry of type 2 diabetes. , 2004, Chemical reviews.

[37]  L. Vatten,et al.  Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis , 2001, British Journal of Cancer.

[38]  G A Colditz,et al.  Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. , 1999, Journal of the National Cancer Institute.

[39]  H. Adami,et al.  Diabetes mellitus and risk of large bowel cancer. , 1997, Journal of the National Cancer Institute.

[40]  A. Cornish-Bowden,et al.  Why is uncompetitive inhibition so rare? , 1986, FEBS letters.